Severe Withdrawal Cases Point to Growing Medetomidine Use

Severe Withdrawal Needing an ICU Sedative More Than Tripled at Two Philadelphia Hospitals as Medetomidine Spread Through Fentanyl

Severe withdrawal needing an ICU sedative rose from 6% to 20% at two Philadelphia hospitals after medetomidine entered the fentanyl supply.

Severe withdrawal cases point to growing medetomidine use

A powerful veterinary sedative, medetomidine, is increasingly appearing in street supplies of the already deadly opioid fentanyl, and the number of patients suffering from medetomidine withdrawal has quadrupled in recent years, according to a new analysis by researchers at the Perelman School of Medicine at the University of Pennsylvania.

Veterinary sedative in fentanyl supply spikes severe withdrawal cases

A powerful veterinary sedative, medetomidine, is increasingly infiltrating the street supplies of the already deadly opioid fentanyl, with patients suffering from its withdrawal quadrupling in recent years, according to a new analysis by researchers at the Perelman School of Medicine at the University of Pennsylvania.

Withdrawal Med Use Points to Increasing Danger of Medetomidine

Growing treatment of severe withdrawal in patients with opioid use points to the consequences of the increase of medetomidine in street fentanyl supply